AI Article Synopsis

  • This study analyzed the rates and clinical impact of procedural myocardial infarction (PMI) in patients with left main coronary artery disease undergoing either percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG), using different definitions for PMI.
  • It found that PMI occurred more frequently after CABG compared to PCI, and both PMI definitions were linked to increased 5-year cardiovascular mortality, although the risk was notably higher after CABG.
  • The results show that while both types of PMI predict long-term mortality, only the more significant elevations in biomarkers are consistently associated with worse outcomes, particularly in CABG patients.

Article Abstract

Background: Varying definitions of procedural myocardial infarction (PMI) are in widespread use.

Objectives: This study sought to determine the rates and clinical relevance of PMI using different definitions in patients with left main coronary artery disease randomized to percutaneous coronary intervention (PCI) versus coronary artery bypass grafting (CABG) surgery in the EXCEL (Evaluation of XIENCE versus Coronary Artery Bypass Surgery for Effectiveness of Left Main Revascularization) trial.

Methods: The pre-specified protocol definition of PMI (PMI) required a large elevation of creatine kinase-MB (CK-MB), with identical threshold for both procedures. The Third Universal Definition of MI (types 4a and 5) (PMI) required lesser biomarker elevations but with supporting evidence of myocardial ischemia, different after PCI and CABG. For the PMI, troponins were used preferentially (available in 49.5% of patients), CK-MB otherwise. The multivariable relationship between each PMI type and 5-year mortality was determined.

Results: PMI occurred in 34 of 935 (3.6%) patients after PCI and 56 of 923 (6.1%) patients after CABG (difference -2.4%; 95% confidence interval [CI]: -4.4% to -0.5%; p = 0.015). The corresponding rates of PMI were 37 (4.0%) and 20 (2.2%), respectively (difference 1.8%; 95% CI: 0.2% to 3.4%; p = 0.025). Both PMI and PMI were associated with 5-year cardiovascular mortality (adjusted hazard ratio [HR]: 2.18 [95% CI: 1.13 to 4.23] and 2.87 [95% CI: 1.44 to 5.73], respectively). PMI was associated with a consistent hazard of cardiovascular mortality after both PCI and CABG (p = 0.86). Conversely, PMI was strongly associated with cardiovascular mortality after CABG (adjusted HR: 11.94; 95% CI: 4.84 to 29.47) but not after PCI (adjusted HR: 1.14; 95% CI: 0.35 to 3.67) (p = 0.004). Results were similar for all-cause mortality and with varying PMI biomarker definitions. Only large biomarker elevations (CK-MB ≥10× upper reference limit and troponin ≥70× upper reference limit) were associated with mortality.

Conclusions: The rates of PMI after PCI and CABG vary greatly with different definitions. In the EXCEL trial, the pre-specified PMI was associated with similar hazard after PCI and CABG, whereas PMI was strongly associated with mortality after CABG but not after PCI. (EXCEL Clinical Trial [EXCEL]; NCT01205776).

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jacc.2020.08.016DOI Listing

Publication Analysis

Top Keywords

pmi associated
20
pmi
17
pci cabg
16
coronary artery
12
cardiovascular mortality
12
myocardial infarction
8
left main
8
pci
8
versus coronary
8
artery bypass
8

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!